Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses.

Clinical trial NCT00199888 · COMPLETED

Trial details

NCT number: NCT00199888
Sponsor: Ludwig Institute for Cancer Research
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer of Kidney Kidney Cancer Renal Cancer Neoplasms, Kidney Renal Neoplasms Renal Cell Carcinoma (RCC)Clear Cell Renal Cell Carcinoma

Start date: 2005-06-01
Primary completion: 2006-03-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.